94. Kongreß pp 195-208 | Cite as

Internistische Komplikationen und klinische Konsequenzen

  • J. Schölmerich
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 94)

Zusammenfassung

Extraintestinale Symptome bei verschiedenen Erkrankungen des Gastrointestinaltraktes sind häufig [14, 40]. Sie können den klinischen Verlauf der Grunderkrankung wesentlich bestimmen und sind oft schwierig zu behandeln. Dies trifft insbesondere auf die extraintestinalen Symptome bei Morbus Crohn und Colitis ulcerosa zu. Man kann diese extraintestinalen Symptome prinzipiell in zwei Gruppen einteilen: die extraintestinalen Manifestationen und die Komplikationen. Beide unterscheiden sich im wesentlichen dadurch, daß die Pathogenese der Manifestationen wie die des Grundleidens ungeklärt, die der Komplikationen aber meist bekannt ist. Da die Manifestation meist äußere Organe wie Haut, Augen oder Gelenke betreffen, sind sie leichter zu diagnostizieren. Hingegen verlaufen die Komplikationen, insbesondere bei Mangelzuständen, oft schleichend und werden erst spät diagnostiziert. Während die Therapie der Manifestationen wie die der Grunderkrankung rein antiinflammatorisch ist, können die Komplikationen wegen ihrer geklärten Pathogenese kausal behandelt werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Andersson H, Bosaeus I, Fasth S, Hellberg R, Hultén L (1987) Cholelithiasis and urolithiasis in Crohn’s disease. Scand J Gastroenterol 22:253–256PubMedCrossRefGoogle Scholar
  2. 2.
    Balzer K, Breuer N, Hotz J, Förster S, Goebell H (1984) Zur Genese von Hyposiderinämie und Anämie beim Morbus Crohn. Dtsch Med Wochenschr 109:1023–1028PubMedCrossRefGoogle Scholar
  3. 3.
    Bush A, Mitchison H, Walt R, Baron JH, Boylston AW, Summerfield JA (1987) Primary biliary cirrhosis and ulcerative colitis. Gastroenterology 92:2009–2013PubMedGoogle Scholar
  4. 4.
    Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, Jewell DP (1986) Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 27:86–91PubMedCrossRefGoogle Scholar
  5. 5.
    Christophi C, Hughes ER (1985) Hepatobiliary disorders in inflammatory bowel disease. Surg Gynecol Obstet 160:187–193PubMedGoogle Scholar
  6. 6.
    Compston JE, Judd D, Drawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J (1987) Osteoporosis in patients with inflammatory bowel disease. Gut 28:410–415PubMedCrossRefGoogle Scholar
  7. 7.
    Desmet VJ, Geboes K (1987) Liver lesions in inflammatory bowel disorders. J Pathol 151:247–255PubMedCrossRefGoogle Scholar
  8. 8.
    Dew MJ, van Berge Henegouwen GP, Huybregts AWM, Allan RN (1980) Hepatotoxic effect of bile acids in inflammatory bowel disease. Gastroenterology 78:1393–1401PubMedGoogle Scholar
  9. 9.
    Dharmsathaphorn K, Freeman DH, Binder HJ, Dobbins JW (1982) Increased risk of nephrolithiasis in patients with steatorrhea. Dig Dis Sci 27:401–405PubMedCrossRefGoogle Scholar
  10. 10.
    Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH (1982) Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology 83:1252–1258PubMedGoogle Scholar
  11. 11.
    Farthing MJG, Dawson AM (1983) Impaired semen quality in Crohn’s disease — drugs, ill health, or undernutrition ? Scand J Gastroenterol 18:57–60PubMedCrossRefGoogle Scholar
  12. 12.
    Filipsson S, Hultén L, Lindstedt G (1978) Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn’s disease. Scand J Gastroenterol 13:529–536PubMedCrossRefGoogle Scholar
  13. 13.
    Glassman M, Kaplan M, Spivak W (1986) Immune-complex glomerulonephritis in Crohn’s disease. J Pediatr Gastroenterol Nutr 5:966–969PubMedCrossRefGoogle Scholar
  14. 14.
    Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis: A study of 700 patients. Medicine 55:401–412PubMedCrossRefGoogle Scholar
  15. 15.
    Greenstein AJ, Sachar DB (1983) Cancer in inflammatory bowel disease. Surv Dig Dis 1:8–18CrossRefGoogle Scholar
  16. 16.
    Greenstein AJ, Gennuso R, Sachar DB, Heimann T, Smith H, Janowitz HD, Aufses AH (1985) Extraintestinal cancers in inflammatory bowel disease. Cancer 56:2914–2921PubMedCrossRefGoogle Scholar
  17. 17.
    Heatley RV, Harries AD (1984) Nutritional support in inflammatory bowel disease. Surv Dig Dis 2:60–72CrossRefGoogle Scholar
  18. 18.
    Hermann E, Mayet E, Poralla WJ, Meyer zum Büschenfelde KH (1988) Rheumatologische Aspekte bei Magen-Darm-Erkrankungen. Klinik und pathologische Aspekte. Z Gastroenterol 26:137–144PubMedGoogle Scholar
  19. 19.
    Heumann R, Sjödahl R, Tobiasson P, Tagesson C (1982) Postprandial serum bile acids in resected and non-resected patients with Crohn’s disease. Scand J Gastroenterol 17:137–140CrossRefGoogle Scholar
  20. 20.
    Holmquist L, Andersson H, Rudic N, Åhrén C, Fällström P (1986) Bile acid malabsorption in children and adolescents with chronic colitis. Scand J Gastroenterol 21:87–92PubMedCrossRefGoogle Scholar
  21. 21.
    Holzbach RT, Marsh ME, Freedman MR, Fazio VW, Lavery IC, Jagelman DA (1980) Portal vein bile acids in patients with severe inflammatory bowel disease. Gut 21:428–435PubMedCrossRefGoogle Scholar
  22. 22.
    Imes S, Dinwoodie A, Walker K, Pinchbeck B, Thomson ABR (1986) Vitamin C status in 137 outpatients with Crohn’s disease. J Clin Gastroenterol 8:443–446PubMedCrossRefGoogle Scholar
  23. 23.
    Imes S, Pinchbeck B, Dinwoodie A, Walker K, Thomson ABR (1987) Vitamin A status in 137 patients with Crohn’s disease. Digestion 37:166–170PubMedCrossRefGoogle Scholar
  24. 24.
    Kirschner BS, Klich JR, Kaiman SS, De Favaro MV, Rosenberg IH (1981) Reversal of growth retardation in Crohn’s disease with therapy emphasizing oral nutritional restitution. Gastroenterology 80:10–15PubMedGoogle Scholar
  25. 25.
    Lederer PC, Cidlinsky K, Kobal G, Lux G (1985) Geschmacksstörungen bei M. Crohn-Patienten — Elektrogustometrie und chemische Geschmacksprüfung. Z Gastroenterol 23:470Google Scholar
  26. 26.
    Lowdell CP, Shousha S, Path MRC, Parkins RA (1986) The incidence of amyloidosis complicating inflammatory bowel disease. A prospective survey of 177 patients. Dis Colon Rectum 29:351–354PubMedCrossRefGoogle Scholar
  27. 27.
    Main ANH, Mills PR, Russel RI, Bronte-Stewart J, Nelson LM, McLeland A, Shenkin A (1983) Vitamin A deficiency ni Crohn’s disease. Gut 24:1169–1175PubMedCrossRefGoogle Scholar
  28. 28.
    Matern S (1982) Chologne Diarrhoe und chologene Steatorrhoe. Z Allgemeinmed 58:601–607Google Scholar
  29. 29.
    McClain C, Su LC, Gilbert H, Cameron D (1983) Zinc-dificiency-induced retinal dysfunction in Crohn’s disease. Dig Dis Sci 28:85–87PubMedCrossRefGoogle Scholar
  30. 30.
    Meyers S, Greenspan J, Greenstein AJ, Cohen BA, Janowitz HD (1987) Pancreatitis coincident with Crohn’s ileocolitis. Report of a case and review of the literature. Dis Colon Rectum 30:119–122PubMedCrossRefGoogle Scholar
  31. 31.
    Miller B (1980) Nebenwirkungen der Therapie mit Salazosulfapyridin. Dtsch Med Wochenschr 105:1596–1597PubMedCrossRefGoogle Scholar
  32. 32.
    Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ (1986) Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 58:1569–1574PubMedCrossRefGoogle Scholar
  33. 33.
    Mir-Madjlessi SH, Farmer RG, Sivak MV (1987) Bile duct carcinoma in patients wit ulcerative colitis. Relationship to sclerosing cholangitis: Report of six cases and review of the literature. Dig Dis Sci 32:145–154PubMedCrossRefGoogle Scholar
  34. 34.
    Müller G, Schütte W, Möller T (1987) Pathogenese von Hyperoxalurien und Kalziumoxalatsteinen bei Darmerkrankungen. Dtsch Z Verdau Stoffwechskr 47:105–112Google Scholar
  35. 35.
    Nishi Y, Lifschitz F, Bayne MA, Daum F, Silverberg M, Aiges H (1980) Zinc status and its relation to growth retardation in children with chronic inflammatory bowel disease. Am J Clin Nutr 33:2613–2621PubMedGoogle Scholar
  36. 36.
    Petras RE, Mir-Jadjlessi SH, Farmer RG (1987) Chron’s disease and intestinal carcinoma. A Report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 93:1307–1314PubMedGoogle Scholar
  37. 37.
    Purrmann J, Bochard F, Thon K, Berges W, Strohmeyer G (1987) Adenokarzinom des Dickdarms bei einer 20jährigen Patientin mit Morbus Crohn. Med Klin 82:40–43Google Scholar
  38. 38.
    Rankin GB, Watts D, Melnyk CS, Kelley ML (1979) National cooperative Crohn’s disease study: Extraintestinal manifestations and perianal complications. Gastroenterology 77:914–920PubMedGoogle Scholar
  39. 39.
    Rutgeerts P, Ghoos Y, Vantrappen G, Fevery J (1986) Biliary lipid composition in patients with nonoperated Crohn’s disease. Dig Dis Sci 31:27–32PubMedCrossRefGoogle Scholar
  40. 40.
    Schölmerich J, Becher M-S, Hoppe-Seyler P, Matern S, Häussinger D, Löhle E, Köttgen E, Gerok W (1985) Zinc and vitamin A deficiency in patients with Crohn’s disease is correlated with activity but not with localization or extent of disease. Hepatogastroenterology 32:34–38Google Scholar
  41. 41.
    Schölmerich J, Hoppe-Seyler P, Gerok W (1986) Extraintestinale Manifestationen bei entzündlichen Darmerkrankungen. Therapiewoche 36:520–532Google Scholar
  42. 42.
    Schölmerich J (1986) Vitamin- und Spurenelementmangel bei entzündlichen Darmerkrankungen. In: Ewe K, Fahrländer H (Hrsg) Therapie chronisch entzündlicher Darmerkrankungen. Schattauer, Stuttgart New York, S 95–107Google Scholar
  43. 43.
    Schölmerich J, Braun G, Volk BA, Spamer C, Hoppe-Seyler P, Gerok W (1987) Detection of extraintestinal and intestinal abnormalities in inflammatory bowel disease by ultrasound. Dig Surg 4:82–87CrossRefGoogle Scholar
  44. 44.
    Schrumpf E, Fausa O, Kolmannskog F, Elgjo K, Rittland S, Gjone E (1982) Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand J Gastroenterol 17:33–39PubMedCrossRefGoogle Scholar
  45. 45.
    Seyrig JA, Jian R, Modigliani R, Golfain D, Florent C, Messing B, Bitoun A (1985) Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci 30:1121–1126PubMedCrossRefGoogle Scholar
  46. 46.
    Solomons NW, Rosenberg IH, Sandstead HH, Vo-Khactu KP (1977) Zinc deficiency in Crohn’s disease. Digestion 16:87–95PubMedCrossRefGoogle Scholar
  47. 47.
    Sommer H, Schmidt M, Gruber KD (1986) Lungenfunktionsstörungen bei Colitis ulcerosa und Morbus Crohn. Dtsch Med Wochenschr 111:812–815PubMedCrossRefGoogle Scholar
  48. 48.
    Talansky AL, Meyers S, Greenstein AJ, Janowitz HD (1983) Does intestinal resection heal the Pyoderma gangraenosum of inflammatory bowel disease. J Clin Gastroenterol 5:207–210PubMedCrossRefGoogle Scholar
  49. 49.
    Talbot RW, Heppell J, Dozois RR, Beart RW (1986) Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140–145PubMedGoogle Scholar
  50. 50.
    Tougaard L, Giese B, Højlund Pedersen B, Binder V (1986) Bile acid metabolism in patients with Crohn’s disease in terminal ileum. Scand J Gastroenterol 21:627–633PubMedCrossRefGoogle Scholar
  51. 51.
    von Westarp C, Thomson ABR, Overton TR, Rogers RM, Hodges PE, Fornasier VL, Crockford PM (1987) Disorders of mineral and bone metabolism in patients with Crohn’s disease. Can J Gastroenterol 1:11–17Google Scholar

Copyright information

© J. F. Bergmann Verlag, München 1988

Authors and Affiliations

  • J. Schölmerich
    • 1
  1. 1.Medizinische UniversitätsklinikFreiburgDeutschland

Personalised recommendations